Knight Therapeutics Inc. upped its stake in Crescita Therapeutics Inc. by 4% to 14.9%.

The company acquired 566,471 new Crescita shares and continues to hold 396,000 warrants, which, if fully exercised, will increase its stake by an additional 2.3%.

The new shares were issued as part of an agreement dated Aug. 31, 2016.

Knight now owns a total of 2,079,973 Crescita shares, which are held for investment purposes.